Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Clene’s CNM-Au8 Shows Decreased Mortality Amyotrophic Lateral Sclerosis Patients

By Vandana Singh
July 14, 9:34 AM
Clene Inc (NASDAQ:CLNN) reported significantly improved survival in Amyotrophic lateral sclerosis (ALS) patients initially treated with CNM-Au8 compared to initially randomized…

CLNN

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News

Lantern Pharma Gets FDA Clearance for Mid-Stage Lung Cancer Study

By Ragothaman Srinivasan
July 14, 9:31 AM
The Food and Drug Administration (FDA) has announced clearance to Lantern Pharma (NASDAQ: LTRN) to proceed with Phase 2 clinical trial of its investigational new drug LP-300 in combination with chemotherapy for never smoker patients with advanced non-small cell lung cancer (N

LTRN

Read More
1 minute read
  • General
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Canoo Shares Pop On Contract To Supply EV To US Army For Analysis

By Shivani Kumaresan
July 14, 9:25 AM
Canoo Inc (NASDAQ:GOEV) is set to supply its electric vehicle to the U.S. Army for analysis and demonstration.  The contract will…

GOEV

Read More
1 minute read
  • General
  • News

Sonoco Inks Global Master Lease Agreement With Turkish Cargo

By Shivani Kumaresan
July 14, 8:56 AM
Sonoco Products Co (NYSE:SON) unit, Sonoco ThermoSafe, and Turkish Airlines have signed a partnership agreement for leasing the new Pegasus ULD temperature-controlled bulk…

SON

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Movers
  • News
  • Trading Ideas

Conagra Brands Reports Mixed Q4 Earnings

By Shivani Kumaresan
July 14, 8:19 AM
Conagra Brands Inc (NYSE:CAG) reported fourth-quarter FY22 sales growth of 6.2% year-on-year to $2.91 billion, missing the consensus of $2.93 billion.…

CAG

Read More
1 minute read
  • Biotech
  • Financing
  • General
  • News

Pasithea Therapeutics Awarded $694K Drug Development Research Grant

By Bill Haddad
July 14, 8:06 AM
-- AUD $1 million (U.S $694,000) grant transferred as part of Alpha-5 Integrin, LLC transaction -- -- Provides approximately U.S. $694,000 of non-dilutive funding -- MIAMI BEACH, Fla., July 14, 2022 (GLOBE NEWSWIRE) --

KTTA

Read More
1 minute read
  • General
  • M&A
  • News

Deutsche Telekom Divests 51% Stake In GD Towers To DigitalBridge & Brookfield

By Shivani Kumaresan
July 14, 7:25 AM
German telecommunications company, Deutsche Telekom AG (OTC:DTEGY), revealed the sale of a 51% ownership stake in GD Towers, comprising its tower business in Germany…

BIP

Read More
1 minute read
  • Asia
  • Contracts
  • Emerging Markets
  • Fintech
  • General
  • Markets
  • News

Barclays Plans To Enter This Lucrative $4.3 Trillion Asset Management Market: Report

By Vandana Singh
July 14, 7:20 AM
Barclays Plc (NYSE:BCS) is seeking a Chinese banking partner to set up an asset management joint venture in the…

BCS

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Large Cap
  • News
  • Tech

Despite Inflationary Pressures, Taiwan Semiconductor Records 76% Jump In Q2 Profits

By Vandana Singh
July 14, 7:18 AM
Taiwan Semiconductor Manufacturing Co Ltd (NYSE: TSM) said its second-quarter profit surged over 76% to NT$237.03 billion (

TSM

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • News

Amryt Receives Orphan Drug Designation From The FDA For Mycapssa For The Treatment Of Carcinoid Syndrome

By Benzinga Newsdesk
July 14, 7:03 AM
Amryt (NASDAQ:AMYT), a global, commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing novel treatments for rare diseases, is pleased to announce that the US Food and Drug

AMYT

Posts pagination

Previous 1 … 2,330 2,331 2,332 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service